SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-006314
Filing Date
2024-02-14
Accepted
2024-02-14 07:35:22
Documents
15
Period of Report
2024-02-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 41466
2 ex99-1.htm EX-99.1 57303
  Complete submission text file 0001493152-24-006314.txt   282679

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sonn-20240214.xsd EX-101.SCH 3018
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sonn-20240214_lab.xml EX-101.LAB 34240
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sonn-20240214_pre.xml EX-101.PRE 22361
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3631
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 24632317
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)